{"id":353565,"date":"2026-11-19T09:29:47","date_gmt":"2026-11-19T03:59:47","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=353565"},"modified":"2026-11-19T09:29:47","modified_gmt":"2026-11-19T03:59:47","slug":"why-kwality-pharmaceuticals-ltd-share-52-week-consecutive-high-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-kwality-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/","title":{"rendered":"Kwality Pharmaceuticals Ltd. (KPL) 52 Week High Streak: Second Straight Session"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/kpl\/kwality-pharmaceuticals-ltd-share-price-today\">Kwality Pharmaceuticals Ltd. (KPL)<\/a> share price reached a fresh 52-week high of Rs 4,274.75 today and later stood at Rs 4,192.5, down 0.07% from the previous close. Market cap was Rs 4,195.25 crore.<\/em><\/div>\n<div>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\"><strong><a href=\"https:\/\/univest.in\/stocks\/kpl\/kwality-pharmaceuticals-ltd-share-price-today\">Kwality Pharmaceuticals Ltd.<\/a> 52 Week High Streak<\/strong> has now extended to its second straight session, with the stock touching a fresh 52-week high of Rs 4,274.75 and moving 3.69% across the streak. At 19 November 2026 at 9:22 AM IST, the latest traded price stood at Rs 4,192.50. The latest Univest figures confirm the repeated-high pattern, but they do not establish a company-specific catalyst for the continued move.<\/p>\n<p style=\"margin-top:0!important;\">Against the previous close of Rs 4,195.25, the stock was slightly lower by Rs 2.75, or 0.07%, after opening at Rs 4,230 and moving between Rs 4,177.10 and Rs 4,274.75. Market capitalisation stood at Rs 4,195.25 crore. For a reader, <strong>Kwality Pharmaceuticals Ltd. 52 Week High Streak<\/strong> is less about a single-day print and more about the fact that the stock has kept resetting its yearly high across consecutive sessions.<\/p>\n<\/div>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-kwality-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#Kwality_Pharmaceuticals_Ltd_52_Week_High_Streak_Consecutive_High_Analysis\" title=\"Kwality Pharmaceuticals Ltd. 52 Week High Streak: Consecutive High Analysis\">Kwality Pharmaceuticals Ltd. 52 Week High Streak: Consecutive High Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-kwality-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#What_the_Repeated_52-Week_Highs_Show\" title=\"What the Repeated 52-Week Highs Show\">What the Repeated 52-Week Highs Show<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-kwality-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#Kwality_Pharmaceuticals_Ltd_KPL_Fundamental_Analysis\" title=\"Kwality Pharmaceuticals Ltd. (KPL) Fundamental Analysis\">Kwality Pharmaceuticals Ltd. (KPL) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-kwality-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-kwality-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-kwality-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#Why_Investors_Are_Watching_Kwality_Pharmaceuticals_Ltd\" title=\"Why Investors Are Watching Kwality Pharmaceuticals Ltd.\">Why Investors Are Watching Kwality Pharmaceuticals Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-kwality-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#About_Kwality_Pharmaceuticals_Ltd\" title=\"About Kwality Pharmaceuticals Ltd.\">About Kwality Pharmaceuticals Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-kwality-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-kwality-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#What_does_Kwality_Pharmaceuticals_Ltd_52_Week_High_Streak_mean\" title=\"What does Kwality Pharmaceuticals Ltd. 52 Week High Streak mean?\">What does Kwality Pharmaceuticals Ltd. 52 Week High Streak mean?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-kwality-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#How_many_sessions_has_Kwality_Pharmaceuticals_Ltd_made_a_fresh_52-week_high\" title=\"How many sessions has Kwality Pharmaceuticals Ltd. made a fresh 52-week high?\">How many sessions has Kwality Pharmaceuticals Ltd. made a fresh 52-week high?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-kwality-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#What_is_the_cumulative_move_across_the_streak\" title=\"What is the cumulative move across the streak?\">What is the cumulative move across the streak?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-kwality-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#What_is_the_latest_52-week_high_for_Kwality_Pharmaceuticals_Ltd\" title=\"What is the latest 52-week high for Kwality Pharmaceuticals Ltd.?\">What is the latest 52-week high for Kwality Pharmaceuticals Ltd.?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-kwality-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#Is_a_company-specific_catalyst_confirmed_for_the_repeated_highs\" title=\"Is a company-specific catalyst confirmed for the repeated highs?\">Is a company-specific catalyst confirmed for the repeated highs?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-kwality-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#How_does_the_valuation_look_after_the_streak\" title=\"How does the valuation look after the streak?\">How does the valuation look after the streak?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-kwality-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#How_does_Kwality_Pharmaceuticals_compare_with_sector_medians\" title=\"How does Kwality Pharmaceuticals compare with sector medians?\">How does Kwality Pharmaceuticals compare with sector medians?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-kwality-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#How_does_the_stock_compare_with_listed_peers\" title=\"How does the stock compare with listed peers?\">How does the stock compare with listed peers?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-kwality-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#Track_Kwality_Pharmaceuticals_Ltd_Share_Price_on_Univest\" title=\"Track Kwality Pharmaceuticals Ltd. Share Price on Univest\">Track Kwality Pharmaceuticals Ltd. Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Kwality_Pharmaceuticals_Ltd_52_Week_High_Streak_Consecutive_High_Analysis\"><\/span><strong>Kwality Pharmaceuticals Ltd. 52 Week High Streak: Consecutive High Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4,192.5<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4,195.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs -2.75 (-0.07%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4,230<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4,274.75<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4,177.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4,195.25 crore<\/td>\n<\/tr>\n<\/table>\n<p>Kwality Pharmaceuticals Ltd. (KPL) traded at Rs 4,192.5 versus the previous close of Rs 4,195.25, a fall of 0.07%. The stock opened at Rs 4,230, reached a high of Rs 4,274.75 and touched a low of Rs 4,177.1.<\/p>\n<p>Kwality Pharmaceuticals Ltd. was trading just below the previous close, while still holding close to its fresh yearly peak. The latest traded price of Rs 4,192.50 was marginally below Rs 4,195.25, and the stock moved down by Rs 2.75, or 0.07%, from that level. The day open of Rs 4,230 placed the stock near the upper part of its intraday band from the start.<\/p>\n<p>The range between Rs 4,177.10 and Rs 4,274.75 shows that the latest trade sat well above the low and just under the fresh high. That high is also the new 52-week high, which is the key marker behind this <strong>Kwality Pharmaceuticals Ltd. 52 Week High Streak<\/strong>. Market capitalisation at Rs 4,195.25 crore places the company in the same broad value band as several listed pharmaceutical peers in the comparison set, even though the stock is trading at a distinct price level from most of them. For this <strong>Kwality Pharmaceuticals Ltd. 52 Week High Streak<\/strong>, the key point is that the repeat high came while the intraday price stayed near the upper end of the day\u2019s band.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_the_Repeated_52-Week_Highs_Show\"><\/span><strong>What the Repeated 52-Week Highs Show<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The repeated-high pattern tells readers that <strong>Kwality Pharmaceuticals Ltd. 52 Week High Streak<\/strong> is not a one-off chart event. The stock has now marked a fresh 52-week high on each of the last two sessions, and the streak move of 3.69% is the clearest numerical sign of that extension. The latest high of Rs 4,274.75 is the reference point for the run so far.<\/p>\n<p>What this also shows is what the data does not show. The numbers confirm a multi-session sequence of new one-year highs, but they do not identify a single company-specific trigger behind the move. That is important for readers tracking <strong>Kwality Pharmaceuticals Ltd. 52 Week High Streak<\/strong>, because the pattern itself is factual, while the cause remains unconfirmed in the latest market data. The previous event trading date was 18 November 2026, so the high was repeated immediately, rather than after a long gap.<\/p>\n<p>In practical terms, the streak lens is different from a one-day breakout lens. A single fresh high can be a brief price event; a second straight session at a new 52-week high suggests the stock has held that higher reference point for longer, which is the core feature of <strong>Kwality Pharmaceuticals Ltd. 52 Week High Streak<\/strong>. The cumulative move is the best way to read the run, not just the latest tick.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Kwality_Pharmaceuticals_Ltd_KPL_Fundamental_Analysis\"><\/span><strong>Kwality Pharmaceuticals Ltd. (KPL) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4,195.25 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">45.36x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.29x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">22.67%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">24.01%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 92.48<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 371.43<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0%<\/td>\n<\/tr>\n<\/table>\n<p>Kwality Pharmaceuticals Ltd. (KPL) fundamental metrics show P\/E 45.36x, P\/B 11.29x, ROE 22.67%, ROCE 24.01%. Taken on their own, these numbers offer context rather than a trading signal.<\/p>\n<p>Kwality Pharmaceuticals Ltd. has a market capitalisation of Rs 4,195.25 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 45.36x, P\/B at 11.29x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 22.67% and ROCE of 24.01%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 92.48, book value per share of Rs 371.43, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 30.5x, median ROE of 11.22%, median ROCE of 13.1%. They set out the fundamental picture and are not a rating on the stock.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">45.36x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">30.5x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">59.35x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.71x to 1,378.1x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.29x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.79x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">22.67%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.22%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">24.01%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4,195.25 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 789.48 crore<\/td>\n<\/tr>\n<\/table>\n<p>Kwality Pharmaceuticals Ltd. (KPL) operates in the Healthcare sector, within the Pharmaceuticals &amp; Drugs industry.<\/p>\n<p>Kwality Pharmaceuticals Ltd. (KPL) has a P\/E ratio of 45.36x, which is above the benchmark median of 30.5x, a difference of +48.72%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Kwality Pharmaceuticals Ltd. (KPL) has a ROE of 22.67%, which is above the benchmark median of 11.22%, a difference of +102.05%. Kwality Pharmaceuticals Ltd. (KPL) has a ROCE of 24.01%, which is above the benchmark median of 13.1%, a difference of +83.28%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/rpglife\/rpg-life-sciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>RPG Life Sciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">RPGLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,212.57<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">37.86<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.03<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.28<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.99<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/guficbio\/gufic-biosciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Gufic Biosciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">GUFICBIO<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,396.39<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">53.09<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.99<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.14<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.56<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/smspharma\/sms-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>SMS Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SMSPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,557.58<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">38.24<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.49<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.32<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/aartidrugs\/aarti-drugs-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Aarti Drugs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">AARTIDRUGS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,589.51<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.18<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.75<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.36<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.04<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/gujthem\/gujarat-themis-biosyn-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Gujarat Themis Biosyn Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">GUJTHEM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,706.29<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">109.74<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.46<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">17.41<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.16<\/td>\n<\/tr>\n<\/table>\n<p>Kwality Pharmaceuticals Ltd. (KPL) has a P\/E ratio of 45.36x compared with the displayed peer median of 38.24x. The comparison is relative and should not be read as a recommendation. Its ROE of 22.67% compares with a peer median of 13.36% across the companies shown in the table. ROCE stood at 24.01% versus the displayed peer median of 13.32%, providing a capital-efficiency comparison. Kwality Pharmaceuticals Ltd. (KPL) has a market capitalisation of Rs 4,195.25 crore. All 5 peers shown have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Kwality_Pharmaceuticals_Ltd\"><\/span><strong>Why Investors Are Watching Kwality Pharmaceuticals Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>The stock has set a fresh 52-week high for its second straight session, which is the defining feature of <strong>Kwality Pharmaceuticals Ltd. 52 Week High Streak<\/strong>.<\/li>\n<li>The cumulative move across the streak is 3.69%, which gives the repeated-high pattern a measurable price context.<\/li>\n<li>The latest high of Rs 4,274.75 is the current reference point for the yearly high run.<\/li>\n<li>P\/E at 45.36 and P\/B at 11.29 place the stock above the industry median on both valuation measures.<\/li>\n<li>ROE of 22.67% and ROCE of 24.01% remain above the industry medians, giving the streak a stronger profitability backdrop than the sector midpoint.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Kwality_Pharmaceuticals_Ltd\"><\/span><strong>About Kwality Pharmaceuticals Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Kwality Pharmaceuticals Ltd. operates in the Pharmaceuticals &amp; Drugs industry within the Healthcare sector. For readers tracking <strong>Kwality Pharmaceuticals Ltd. 52 Week High Streak<\/strong>, the main context is that this is a listed pharmaceutical company with a market capitalisation of Rs 4,195.25 crore and a valuation profile that is materially above the industry median. The company\u2019s return ratios also sit above the industry centre, which is why the streak is being assessed against both price and fundamentals rather than price alone.<\/p>\n<p>That business context is enough to frame the streak without drifting into unrelated company detail. The key question now is how long the repeated yearly-high pattern can continue and whether the valuation premium remains supported by the current profitability metrics in the listed pharmaceutical universe.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_does_Kwality_Pharmaceuticals_Ltd_52_Week_High_Streak_mean\"><\/span><strong>What does Kwality Pharmaceuticals Ltd. 52 Week High Streak mean?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> It means the stock has marked a fresh 52-week high on consecutive sessions. In this case, Kwality Pharmaceuticals Ltd. has done so for its second straight session, which makes the pattern more notable than a one-day breakout.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_many_sessions_has_Kwality_Pharmaceuticals_Ltd_made_a_fresh_52-week_high\"><\/span><strong>How many sessions has Kwality Pharmaceuticals Ltd. made a fresh 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> According to the latest market data, the stock has set a fresh 52-week high for two consecutive sessions.,<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_cumulative_move_across_the_streak\"><\/span><strong>What is the cumulative move across the streak?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The cumulative streak change is 3.69%. That figure captures the full move across the repeated-high run better than looking at the latest trade in isolation.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_latest_52-week_high_for_Kwality_Pharmaceuticals_Ltd\"><\/span><strong>What is the latest 52-week high for Kwality Pharmaceuticals Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The latest fresh 52-week high is Rs 4,274.75. That level is the current reference point for the Kwality Pharmaceuticals Ltd. 52 Week High Streak. The stock moved -0.07% so far today.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_a_company-specific_catalyst_confirmed_for_the_repeated_highs\"><\/span><strong>Is a company-specific catalyst confirmed for the repeated highs?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No confirmed company-specific catalyst is established by the latest market data. The numbers confirm the repeated-high pattern, but they do not identify a single reason for it.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_the_valuation_look_after_the_streak\"><\/span><strong>How does the valuation look after the streak?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock trades at a P\/E of 45.36 and a P\/B of 11.29, both above the industry medians. Because the streak does not change earnings or book value, the change in multiples comes from price.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Kwality_Pharmaceuticals_compare_with_sector_medians\"><\/span><strong>How does Kwality Pharmaceuticals compare with sector medians?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Its P\/E and P\/B are above the healthcare industry medians, while ROE and ROCE are also above the medians. That combination gives the streak a stronger profitability base than the sector midpoint, alongside a premium valuation.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_the_stock_compare_with_listed_peers\"><\/span><strong>How does the stock compare with listed peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Within the displayed peer set, Kwality Pharmaceuticals Ltd. trades above several peers on both P\/E and P\/B. It remains below Gujarat Themis Biosyn Ltd. on P\/E, but it is in the upper valuation band of the group shown.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What does Kwality Pharmaceuticals Ltd. 52 Week High Streak mean?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"It means the stock has marked a fresh 52-week high on consecutive sessions. In this case, Kwality Pharmaceuticals Ltd. has done so for its second straight session, which makes the pattern more notable than a one-day breakout.\"}},{\"@type\":\"Question\",\"name\":\"How many sessions has Kwality Pharmaceuticals Ltd. made a fresh 52-week high?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"According to the latest market data, the stock has set a fresh 52-week high for two consecutive sessions. The streak label used for the latest event is, second straight session.,\"}},{\"@type\":\"Question\",\"name\":\"What is the cumulative move across the streak?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The cumulative streak change is 3.69%. That figure captures the full move across the repeated-high run better than looking at the latest trade in isolation.\"}},{\"@type\":\"Question\",\"name\":\"What is the latest 52-week high for Kwality Pharmaceuticals Ltd.?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The latest fresh 52-week high is Rs 4,274.75. That level is the current reference point for the Kwality Pharmaceuticals Ltd. 52 Week High Streak. The stock moved -0.07% so far today.\"}},{\"@type\":\"Question\",\"name\":\"Is a company-specific catalyst confirmed for the repeated highs?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No confirmed company-specific catalyst is established by the latest market data. The numbers confirm the repeated-high pattern, but they do not identify a single reason for it.\"}},{\"@type\":\"Question\",\"name\":\"How does the valuation look after the streak?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The stock trades at a P\/E of 45.36 and a P\/B of 11.29, both above the industry medians. Because the streak does not change earnings or book value, the change in multiples comes from price.\"}},{\"@type\":\"Question\",\"name\":\"How does Kwality Pharmaceuticals compare with sector medians?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Its P\/E and P\/B are above the healthcare industry medians, while ROE and ROCE are also above the medians. That combination gives the streak a stronger profitability base than the sector midpoint, alongside a premium valuation.\"}},{\"@type\":\"Question\",\"name\":\"How does the stock compare with listed peers?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Within the displayed peer set, Kwality Pharmaceuticals Ltd. trades above several peers on both P\/E and P\/B. It remains below Gujarat Themis Biosyn Ltd. on P\/E, but it is in the upper valuation band of the group shown.\"}}]}<\/script><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Track_Kwality_Pharmaceuticals_Ltd_Share_Price_on_Univest\"><\/span><strong>Track Kwality Pharmaceuticals Ltd. Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/kpl\/kwality-pharmaceuticals-ltd-share-price-today\">Kwality Pharmaceuticals Ltd. (KPL) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Follow <strong>Kwality Pharmaceuticals Ltd. 52 Week High Streak<\/strong> closely if you want to monitor how the stock behaves around its fresh yearly high, the latest traded price and the valuation gap versus the industry median. The repeated-high pattern is the main event, while the financial ratios and peer comparisons provide the wider frame for reading the move.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Kwality Pharmaceuticals Ltd. Share Price hit a fresh 52-week high of Rs 4,274.75 today and is trading at Rs 4,192.50, down 0.07% on the day. Market cap stands at Rs 4,195.25 crore.<\/p>\n","protected":false},"author":35,"featured_media":353562,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-353565","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["353562"],"rank_math_title":["Kwality Pharmaceuticals Ltd. 52 Week High Streak Explained"],"rank_math_description":["Kwality Pharmaceuticals Ltd. 52 Week High Streak: Kwality Pharmaceuticals Ltd. has set a fresh 52-week high for its second straight session. See the streak"],"rank_math_focus_keyword":["Kwality Pharmaceuticals Ltd. 52 Week High Streak"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/Kwality_Pharmaceuticals_Ltd_KPL_52_Week_High_Streak_Second_Straight_Session_bullish.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/353565","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=353565"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/353565\/revisions"}],"predecessor-version":[{"id":353566,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/353565\/revisions\/353566"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/353562"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=353565"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=353565"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=353565"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}